SEC Filing Summary
Registrant and period: The filing is a Form 8-K filed by Akerna Corp. on September 22, 2023, reporting events occurring on September 19, 2023. The request metadata identifies American Bitcoin Corp., but the filing itself identifies Akerna Corp. as the registrant.
Business Context and Reporting Period
Akerna is a Delaware corporation whose common stock and warrants traded on the Nasdaq Capital Market under the symbols KERN and KERNW. The filing concerns Nasdaq continued-listing deficiencies and the company’s proposed transactions with Gryphon Digital Mining, Inc. and MJ Acquisition Corp.
Key Financial Metrics and Liquidity
- The filing does not provide current revenue, profit, cash flow, margin, debt, cash balance, or liquidity figures.
- Akerna previously reported stockholders’ equity below Nasdaq’s $2.5 million minimum requirement under Listing Rule 5550(b)(1), based on its Form 10-K for the year ended December 31, 2022.
- The filing states that the company faces risks regarding its ability to manage operating expenses and transaction-related expenses and to obtain sufficient additional capital to continue its business plan.
Material Changes Versus the Prior Comparable Period
- On September 19, 2023, Nasdaq determined that Akerna had not regained compliance with the $1.00 minimum bid-price requirement under Listing Rule 5550(a)(2) by the September 18 deadline.
- Nasdaq also identified the company’s stockholders’ equity deficiency as a separate basis for potential delisting after an extension to regain compliance expired.
- Unless Akerna appealed, trading suspension was scheduled to begin at the opening of business on September 28, 2023, with a Form 25-NSE to follow.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Akerna stated that it planned to appeal Nasdaq’s determination by 4:00 p.m. Eastern Time on September 26, 2023, and request a hearing before a Nasdaq Hearing Panel.
- A timely hearing request would stay the suspension or delisting action pending the Panel’s decision, and the common stock would remain listed while the appeal was pending.
- The company expected its transactions with Gryphon and MJ Acquisition Corp., including a proposed reverse stock split, to be completed or near completion before the hearing and to support a request for additional time to regain compliance.
- There was no assurance that the Panel would grant continued listing, that the transactions would close, or that Akerna would regain compliance.
- Potential delisting could reduce trading liquidity and quotation accuracy, materially depress the stock price, impair capital-raising ability, and trigger defaults or penalties under outstanding agreements or securities.
- Additional transaction risks include failure to obtain stockholder or regulatory approvals, delays in closing, unexpected costs, changes in the exchange ratio, adverse business reactions, and failure to realize anticipated transaction benefits.
Most Important Facts for Investors to Verify
- Whether Akerna timely filed its Nasdaq appeal and whether the Hearing Panel stayed suspension or delisting.
- Whether the Gryphon and MJ Acquisition Corp. transactions closed and whether the proposed reverse stock split occurred.
- Whether Akerna regained compliance with both the $1.00 minimum bid-price requirement and the $2.5 million stockholders’ equity requirement.
- The company’s latest cash balance, operating cash burn, debt obligations, stockholders’ equity, and need for additional financing, which are not provided in this filing.
- The latest SEC filings and proxy statement/prospectus for transaction terms, exchange-ratio adjustments, required approvals, and dilution.